Clinical trials
Completed trials in Belarus
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
245 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 8 |
| 2008 | 17 |
| 2009 | 15 |
| 2010 | 16 |
| 2011 | 13 |
| 2012 | 11 |
| 2013 | 16 |
| 2014 | 22 |
| 2015 | 15 |
| 2016 | 17 |
| 2017 | 22 |
| 2018 | 15 |
| 2019 | 20 |
| 2020 | 17 |
| 2021 | 5 |
| 2022 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 245 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 20 |
| Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 14 |
| Actelion | 10 |
| AbbVie | 9 |
| Biocad | 9 |
| Astellas Pharma Europe B.V. | 5 |
| Astellas Pharma Inc | 5 |
| Celgene | 5 |
| Hoffmann-La Roche | 5 |
| Octapharma | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 14 |
| Colitis, Ulcerative | 14 |
| Multiple Sclerosis | 11 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Arthritis, Rheumatoid | 8 |
| Venous Thromboembolism | 8 |
| Crohn Disease | 7 |
| Pulmonary Arterial Hypertension | 6 |
| Lupus Erythematosus, Systemic | 5 |
| Multiple Sclerosis, Relapsing-Remitting | 5 |
Trials
Showing 26 to 50 of 245. Each trial links to its page on Pharma Observatory.
145 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.